COVID-19 THERAPEUTIC ALERT – ANTIMICROBIALS (AZITHROMYCIN AND DOXYCYCLINE) NOT BENEFICIAL IN THE MANAGEMENT OF COVID-19 – (SARS-CoV-2) POSITIVE PATIENTS

Azithromycin should NOT be used in the management of confirmed or suspected COVID-19 infection either within primary care or in hospitalised patients, unless there are additional indications for which its use remains appropriate (see Product Details).

Doxycycline should NOT be used in the management of confirmed or suspected COVID-19 infection within primary care, unless there are additional indications for which its use remains appropriate (see Product Details).